Stadtwerke Kiel and INNIO plan to achieve climate neutrality at the coastal power plant in Kiel by 2035. • As the world’s first 190 MW large-scale engine-based combined heat and power plant, the coastal power plant is planned to be converted to hydrogen operations. • 20 Jenbacher engines are to be converted to run on […]
Day: March 9, 2023
Stadtwerke Kiel and INNIO Set Global Standards for Climate Neutral Energy Supply by 2035
Stadtwerke Kiel and INNIO plan to achieve climate neutrality at the coastal power plant in Kiel by 2035. • As the world’s first 190 MW large-scale engine-based combined heat and power plant, the coastal power plant is planned to be converted to hydrogen operations. • 20 Jenbacher engines are to be converted to run on […]
Stadtwerke Kiel and INNIO Set Global Standards for Climate Neutral Energy Supply by 2035
Stadtwerke Kiel and INNIO plan to achieve climate neutrality at the coastal power plant in Kiel by 2035. • As the world’s first 190 MW large-scale engine-based combined heat and power plant, the coastal power plant is planned to be converted to hydrogen operations. • 20 Jenbacher engines are to be converted to run on […]
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 Mont-Saint-Guibert, Belgium – March 8, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that […]
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 Mont-Saint-Guibert, Belgium – March 8, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that […]
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 Mont-Saint-Guibert, Belgium – March 8, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that […]